跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
I-32
首页
药物
I-32
I-32
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FORMULATIONS WITH ENHANCED SN-38 SOLUBILITY AND ORAL ABSORPTION
EP 4395764 A4
申请人: TAIRX INC
优先权: 2021
CN
EP
US
WO
6 件公开
BNP(1-32) epitope and antibodies directed against said epitope
US 9481720 B2
申请人: RIEUNIER FRANCOIS
优先权: 2007
CN
US
5 件公开
METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
EP 3981420 A1
申请人: MALLINCKRODT PHARMACEUTICALS IRELAND LTD
优先权: 2014
CN
EP
5 件公开
Deposition system for hair
US 12458574 B2
申请人: CONOPCO INC
优先权: 2018
CN
EP
US
WO
4 件公开
US 12285507 B2
申请人: CONOPCO INC
优先权: 2018
CN
US
2 件公开
US 12280131 B2
申请人: CONOPCO INC
优先权: 2018
CN
US
2 件公开
Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including Lactobacillus delbrueckii subsp. bulgaricus and N-acetyl D-glucosamine
US 8007783 B2
申请人: MILLER CARL
优先权: 2006
US
4 件公开
Hair removal device comprising a modifying surfactant
EP 2517693 B1
申请人: GILLETTE CO LLC
优先权: 2011
CN
EP
US
3 件公开
LIPID AND COMPOSITION
US 2024148664 A1
申请人: SOGO PHARM
优先权: 2021
CN
EP
US
3 件公开
PHARMACEUTICAL DOSAGE FORMS COMPRISING (4)-2.4-CHLORO-4-ETHYL-7. 3-FLUORO-3.5-METHOXY-3.2,5- DIOXO-1.4-(TRIFLUOROMETHYL)-3 .2H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-7.4-CARBOXAMIDE
EP 4687831 A1
申请人: BAYER AG
优先权: 2023
CN
EP
WO
3 件公开
Fluorescent diketopyrrolopyrrole analogues
US 7041235 B2
申请人: CIBA SC HOLDING AG
优先权: 2001
CN
US
3 件公开
Hydrophobically modified saccharide surfactants
EP 1304158 A1
申请人: TIENSE SUIKERRAFFINADERIJ NV
优先权: 2001
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈